← All companies

STTK

Shattuck Labs, Inc.

STTK Nasdaq Pharmaceutical Preparations EDGAR ↗

$7.29

+0.10 +1.39%

Key statistics

from XBRL data in SEC filings

Market cap

$559M

Revenue (TTM)

$1.00M

Net income (TTM)

-$49.9M

EPS (TTM)

$-0.56

P/E ratio

—

Dividend yield

—

Free cash flow

-$40.0M

Cash

$90.4M

Total assets

$102M

Gross margin

—

52-week range

$0.71 – $8.33

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Entered a material agreement Jun 11, 2026 8-K Regulation FD disclosure; Other events Jun 9, 2026 8-K Director or officer change; Shareholder vote results Jun 2, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Results of operations (earnings release) May 7, 2026 10-K Fiscal year ended 2025-12-31 Mar 5, 2026 8-K Results of operations (earnings release) Mar 5, 2026 8-K Other events Feb 5, 2026 8-K Entered a material agreement Jan 22, 2026 8-K/A Results of operations (earnings release) Nov 6, 2025 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release) Nov 6, 2025 8-K Director or officer change; Regulation FD disclosure Aug 26, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Results of operations (earnings release) Aug 14, 2025 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Aug 5, 2025 8-K Shareholder vote results Jul 15, 2025 10-Q Quarter ended 2025-03-31 May 1, 2025 8-K Results of operations (earnings release) May 1, 2025 10-K/A Fiscal year ended 2024-12-31 May 1, 2025 10-K/A Fiscal year ended 2024-12-31 Apr 30, 2025 10-K Fiscal year ended 2024-12-31 Mar 27, 2025 8-K Results of operations (earnings release) Mar 27, 2025 10-Q Quarter ended 2024-09-30 Nov 14, 2024 8-K Results of operations (earnings release) Nov 14, 2024 8-K Terminated a material agreement; Exit or disposal costs; Other events Oct 1, 2024 10-Q Quarter ended 2024-06-30 Aug 1, 2024 8-K Results of operations (earnings release) Aug 1, 2024 8-K Regulation FD disclosure Jun 14, 2024 8-K/A Director or officer change Jun 11, 2024 8-K Shareholder vote results Jun 10, 2024 10-Q Quarter ended 2024-03-31 May 2, 2024 8-K Results of operations (earnings release) May 2, 2024 8-K Director or officer change; Regulation FD disclosure Mar 4, 2024 10-K Fiscal year ended 2023-12-31 Feb 29, 2024 8-K Results of operations (earnings release) Feb 29, 2024 8-K Entered a material agreement Feb 13, 2024 8-K Entered a material agreement; Unregistered sale of equity Dec 22, 2023 8-K Other events Dec 21, 2023 8-K Regulation FD disclosure Dec 13, 2023